ZEAB Therapeutic LTD is currently carrying out development activities for Colorectal cancer cure with a patent application. The activities include ADME Investigation (in-vitro and in-vivo) in collaboration with reputable institutions.
(University of East London U.K., BIDMC – Harvard Medical School, U.S.A.)
ZEAB Therapeutic is also engaging the services of Cresset BioMolecular Discovery U.K. and Human Metabolome Technology U.S.A.

ZEAB Therapeutic is also engaging the services of Cresset BioMolecular Discovery U.K. and Human Metabolome Technology U.S.A.